CERTIFICATION EXAM 2026/2027 | Complete
Study Guide | Practice Questions, Verified
Answers & Detailed Rationales
AANP FAMILY NURSE PRACTITIONER (FNP) CERTIFICATION EXAM 2026/2027
Complete Study Guide | Practice Questions, Verified Answers & Detailed
Rationales
DOCUMENT OVERVIEW
• This comprehensive study material contains practice questions modeled after the
actual AANP FNP certification exam, providing extensive review across all major
clinical domains to enhance retention and exam readiness.
• Study strategy: Work through questions systematically by topic area, review
incorrect answers carefully with detailed rationales, and repeat challenging sections
to reinforce knowledge gaps and build clinical confidence.
PRACTICE QUESTIONS
QUESTION 1
A 45-year-old male presents with chest pain radiating to the left arm and
diaphoresis. His blood pressure is 165/95 mmHg, heart rate 105 bpm, and
troponin I is 2.5 ng/mL (normal <0.04). Which intervention should be initiated
immediately?
A) Observation for 4 hours with serial troponins
B) Nitroglycerin, aspirin, and emergency cardiac catheterization
C) Discharge home with scheduled follow-up in 1 week
D) Start metoprolol and arrange stress testing for tomorrow
E) Administer oxygen and wait for EKG results
,CORRECT ANSWER: B - Nitroglycerin, aspirin, and emergency cardiac
catheterization
Rationale: This patient presents with classic acute ST-elevation myocardial
infarction (STEMI) symptoms with elevated troponin. Immediate interventions
include antiplatelet therapy (aspirin), vasodilation (nitroglycerin), and urgent
reperfusion therapy via primary percutaneous coronary intervention (PCI). Time to
treatment is critical; delays significantly increase mortality. Options A, C, D, and E
represent inappropriate delays in definitive management.
QUESTION 2
A 28-year-old woman on oral contraceptives presents with unilateral leg
swelling, calf pain, and a positive Homan's sign. Doppler ultrasound confirms
deep vein thrombosis (DVT). What is the appropriate initial management?
A) Compression stockings and NSAIDs for symptom relief
B) Immediate anticoagulation with unfractionated heparin or LMWH followed by
warfarin
C) Discontinue oral contraceptives and monitor for resolution
D) Prescribe aspirin as antiplatelet therapy
E) Recommend bed rest for 2 weeks, then gradual mobilization
CORRECT ANSWER: B - Immediate anticoagulation with unfractionated
heparin or LMWH followed by warfarin
Rationale: DVT requires immediate anticoagulation to prevent pulmonary embolism
and propagation of the thrombus. Standard therapy includes initial parenteral
anticoagulation (unfractionated heparin or LMWH) bridged to warfarin (target INR
2-3) for 3 months minimum. Discontinuing contraceptives alone is insufficient;
anticoagulation is essential. NSAIDs, compression alone, aspirin monotherapy, and
bed rest do not address the acute thrombotic process adequately.
,QUESTION 3
A 52-year-old male with type 2 diabetes and hypertension presents with a
fasting blood glucose of 180 mg/dL and HbA1c of 8.2%. He is currently on
metformin 1000 mg twice daily. Which agent should be added to achieve
better glycemic control?
A) Insulin glargine 10 units subcutaneously daily
B) A second-generation sulfonylurea such as glyburide
C) A GLP-1 receptor agonist or SGLT2 inhibitor
D) Acarbose for postprandial glucose control
E) Rosiglitazone for improved insulin sensitivity
CORRECT ANSWER: C - A GLP-1 receptor agonist or SGLT2 inhibitor
Rationale: Current diabetes guidelines recommend adding a GLP-1 agonist (e.g.,
semaglutide, dulaglutide) or SGLT2 inhibitor (e.g., empagliflozin, canagliflozin) to
metformin as second-line therapy. These agents offer cardiovascular and renal
protective benefits, modest weight loss, and low hypoglycemia risk. This patient's
HbA1c of 8.2% indicates suboptimal control on monotherapy. Sulfonylureas
increase hypoglycemia and weight gain risk; insulin is premature at this stage;
acarbose has limited efficacy; rosiglitazone increases heart failure risk and is less
favored.
QUESTION 4
A 67-year-old woman with a history of hypertension presents with sudden-
onset worst headache of her life, neck stiffness, and photophobia. CT head is
negative. What is the most likely diagnosis and next step?
A) Tension headache; prescribe sumatriptan and NSAIDs
B) Subarachnoid hemorrhage (SAH); perform lumbar puncture
C) Migraine with aura; start prophylactic therapy
D) Bacterial meningitis; begin empiric antibiotics after LP
, E) Intracranial mass; schedule MRI for the following week
CORRECT ANSWER: B - Subarachnoid hemorrhage (SAH); perform lumbar
puncture
Rationale: Classic presentation of SAH includes sudden severe headache
("thunderclap"), neck stiffness, and photophobia. When CT head is negative but
clinical suspicion remains high, lumbar puncture is indicated to detect
xanthochromia from blood breakdown products. Early diagnosis is critical to
prevent rebleeding and vasospasm. While bacterial meningitis must be considered,
CSF analysis will differentiate. Tension headache and migraine do not present this
acutely and severely. MRI delay is inappropriate for acute SAH.
QUESTION 5
A 35-year-old man presents with progressive dyspnea on exertion, orthopnea,
and lower extremity edema. Echocardiography shows ejection fraction of 35%
and dilated left ventricle. Which medication should be initiated as
foundational therapy?
A) Diuretics alone for symptom management
B) An ACE inhibitor or ARB to reduce afterload
C) Beta-blocers for rate control only
D) Digoxin for positive inotropic effect
E) Calcium channel blockers for ventricular remodeling prevention
CORRECT ANSWER: B - An ACE inhibitor or ARB to reduce afterload
Rationale: In systolic heart failure (ejection fraction ≤40%), ACE inhibitors and ARBs
are foundational, evidence-based therapies that reduce mortality and morbidity by
inhibiting neurohormonal activation and preventing ventricular remodeling. These
should be initiated alongside beta-blockers (e.g., carvedilol, metoprolol) as first-line
agents. Diuretics manage congestion but do not alter prognosis. Digoxin has
minimal mortality benefit. Calcium channel blockers are contraindicated in systolic
heart failure.